Lilly’s GLP-1 pill outperforms Novo’s oral treatment in diabetes study Orforglipron led to lower blood sugar and weight loss than Rybelsus in trial

https://www.statnews.com/2025/09/17/eli-lilly-orforglipron-rybelsus-results/